1 Rugo HS. Achieving Improved Survival Outcomes in Advanced Breast Cancer. The New England journal of medicine. 2019; 381: 371-72.
2 Harbeck N, Gnant M. Breast cancer. Lancet (London, England). 2017; 389: 1134-50.
3 Xu S, Kong D, Chen Q, Ping Y, Pang D. Oncogenic long noncoding RNA landscape in breast cancer. Molecular cancer. 2017; 16: 129.
4 Ellis M. Genomic analysis of breast cancer heralds a changing treatment paradigm. Journal of the National Comprehensive Cancer Network : JNCCN. 2014; 12: 750-2.
5 Feng H, Gu ZY, Li Q, Liu QH, Yang XY, Zhang JJ. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis. Journal of ovarian research. 2019; 12: 35.
6 Yan H, Zheng G, Qu J, et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. Journal of cellular physiology. 2019.
7 Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science (New York, NY). 2013; 339: 1546-58.
8 Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic acids research. 2013; 41: D991-5.
9 Expansion of the Gene Ontology knowledgebase and resources. Nucleic acids research. 2017; 45: D331-d38.
10 Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research. 2000; 28: 27-30.
11 Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic acids research. 2015; 43: D447-52.
12 Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic acids research. 2017; 45: W98-w102.
13 Zhang S, Nguyen LH, Zhou K, et al. Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology. 2018; 154: 1421-34.
14 Zhou W, Wang Z, Shen N, et al. Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer. Molecular and cellular biochemistry. 2015; 398: 11-9.
15 Lian YF, Huang YL, Wang JL, et al. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma. Aging. 2018; 10: 1884-901.
16 Suzuki C, Daigo Y, Ishikawa N, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer research. 2005; 65: 11314-25.
17 Wang Z, Chen J, Zhong MZ, et al. Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer chemotherapy and pharmacology. 2017; 79: 535-43.
18 Hosokawa M, Takehara A, Matsuda K, et al. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer research. 2007; 67: 2568-76.
19 Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung cancer (Amsterdam, Netherlands). 2012; 75: 110-8.
20 Zhu K, Diao D, Dang C, et al. Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer. Cancer science. 2013; 104: 353-9.
21 Cheng Y, Li K, Diao D, et al. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Laboratory investigation; a journal of technical methods and pathology. 2013; 93: 1276-87.
22 Lv W, Su B, Li Y, Geng C, Chen N. KIAA0101 inhibition suppresses cell proliferation and cell cycle progression by promoting the interaction between p53 and Sp1 in breast cancer. Biochemical and biophysical research communications. 2018; 503: 600-06.
23 Gai M, Bianchi FT, Vagnoni C, et al. ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules. EMBO reports. 2016; 17: 1396-409.
24 Saunders RD, Avides MC, Howard T, Gonzalez C, Glover DM. The Drosophila gene abnormal spindle encodes a novel microtubule-associated protein that associates with the polar regions of the mitotic spindle. The Journal of cell biology. 1997; 137: 881-90.
25 Tang J, Lu M, Cui Q, et al. Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis. Frontiers in oncology. 2019; 9: 310.
26 Turnbull AK, Arthur LM, Renshaw L, et al. Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015; 33: 2270-8.
27 Qian X, Song X, He Y, et al. CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2015; 74: 222-7.
28 Shubbar E, Kovács A, Hajizadeh S, et al. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome. BMC cancer. 2013; 13: 1.
29 Hall CL, Yang B, Yang X, et al. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell. 1995; 82: 19-26.
30 Tilghman J, Wu H, Sang Y, et al. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer research. 2014; 74: 3168-79.
31 Wang C, Thor AD, Moore DH, et al. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998; 4: 567-76.
32 Pujana MA, Han JD, Starita LM, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007; 39: 1338-49.
33 Ayad NG, Rankin S, Murakami M, Jebanathirajah J, Gygi S, Kirschner MW. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell. 2003; 113: 101-13.
34 Itzel T, Scholz P, Maass T, et al. Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis. Bioinformatics (Oxford, England). 2015; 31: 216-24.
35 Qian W, Zhang Z, Peng W, et al. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer. International journal of oncology. 2018; 53: 2021-33.
36 Koffa MD, Casanova CM, Santarella R, Köcher T, Wilm M, Mattaj IW. HURP is part of a Ran-dependent complex involved in spindle formation. Current biology : CB. 2006; 16: 743-54.
37 Wong J, Lerrigo R, Jang CY, Fang G. Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain. Molecular biology of the cell. 2008; 19: 2083-91.
38 Chen X, Thiaville MM, Chen L, et al. Defining NOTCH3 target genes in ovarian cancer. Cancer research. 2012; 72: 2294-303.
39 Zhang X, Pan Y, Fu H, Zhang J. Nucleolar and Spindle Associated Protein 1 (NUSAP1) Inhibits Cell Proliferation and Enhances Susceptibility to Epirubicin In Invasive Breast Cancer Cells by Regulating Cyclin D Kinase (CDK1) and DLGAP5 Expression. Medical science monitor : international medical journal of experimental and clinical research. 2018; 24: 8553-64.
40 Wordeman L, Mitchison TJ. Identification and partial characterization of mitotic centromere-associated kinesin, a kinesin-related protein that associates with centromeres during mitosis. The Journal of cell biology. 1995; 128: 95-104.
41 Andrews PD, Ovechkina Y, Morrice N, et al. Aurora B regulates MCAK at the mitotic centromere. Developmental cell. 2004; 6: 253-68.
42 Shimo A, Tanikawa C, Nishidate T, et al. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer science. 2008; 99: 62-70.
43 Heyer BS, Warsowe J, Solter D, Knowles BB, Ackerman SL. New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo. Molecular reproduction and development. 1997; 47: 148-56.
44 Giuliano CJ, Lin A, Smith JC, Palladino AC, Sheltzer JM. MELK expression correlates with tumor mitotic activity but is not required for cancer growth. eLife. 2018; 7.
45 Huang HT, Seo HS, Zhang T, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. eLife. 2017; 6.
46 Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer research. 2004; 64: 7370-6.
47 Kim S, Lee K, Choi JH, Ringstad N, Dynlacht BD. Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle. Nature communications. 2015; 6: 8087.
48 Cappello P, Blaser H, Gorrini C, et al. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells. Oncogene. 2014; 33: 2375-84.
49 Ejlertsen B, Tuxen MK, Jakobsen EH, et al. Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017; 35: 2639-46.
50 Zheng H, Li X, Chen C, et al. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer. International journal of nanomedicine. 11: 5519-29.
51 Chen JR, Chien HP, Chen KS, et al. Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer. Medicine. 2017; 96: e5582.
52 Yang Y, Li DP, Shen N, et al. TPX2 promotes migration and invasion of human breast cancer cells. Asian Pacific journal of tropical medicine. 2015; 8: 1064-70.
53 Cocchiola R, Grillo C, Altieri F, Chichiarelli S, Turano C, Eufemi M. Upregulation of TPX2 by STAT3: identification of a novel STAT3 binding site. PloS one. 2014; 9: e113096.
54 Huang C, Han Z, Wu D. Effects of gene on radiotherapy sensitization in breast cancer stem cells. Oncology letters. 2017; 14: 1531-35.
55 Mo CH, Gao L, Zhu XF, et al. The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data. Cancer cell international. 2017; 17: 83.
56 Loussouarn D, Campion L, Leclair F, et al. Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. British journal of cancer. 2009; 101: 166-73.
57 Chou CP, Huang NC, Jhuang SJ, et al. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PloS one. 2014; 9: e93934.
58 Qin T, Huang G, Chi L, et al. Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017; 95: 649-55.
59 Morreale FE, Bortoluzzi A, Chaugule VK, Arkinson C, Walden H, Ciulli A. Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening. Journal of medicinal chemistry. 2017; 60: 4093-98.
60 Perez-Peña J, Corrales-Sánchez V, Amir E, Pandiella A, Ocana A. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers. Scientific reports. 2017; 7: 17530.
61 Ueki T, Park JH, Nishidate T, et al. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer research. 2009; 69: 8752-60.